Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Orexin 1 Receptor Activation Attenuates Neurogenic Dural Vasodilation in an Animal Model of Trigeminovascular Nociception

P. R. Holland, S. Akerman and P. J. Goadsby
Journal of Pharmacology and Experimental Therapeutics December 2005, 315 (3) 1380-1385; DOI: https://doi.org/10.1124/jpet.105.090951
P. R. Holland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Akerman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. J. Goadsby
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 315 no. 3 1380-1385
DOI 
https://doi.org/10.1124/jpet.105.090951
PubMed 
16160082

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received June 14, 2005
  • Accepted September 8, 2005
  • Published online November 16, 2005.

Article Versions

  • Earlier version (September 13, 2005 - 11:39).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. P. R. Holland,
  2. S. Akerman and
  3. P. J. Goadsby
  1. Headache Group, Institute of Neurology, London, United Kingdom
  1. Address correspondence to:
    Prof. P. J. Goadsby, Institute of Neurology, Queen Square, London WC1N 3BG, UK. E-mail: peterg{at}ion.ucl.ac.uk
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2005 to May 2023

AbstractFullPdf
Sep 200533086
Oct 200515061
Nov 2005353476
Dec 2005374638
Jan 2006221818
Feb 2006242314
Mar 2006122521
Apr 200691518
May 2006121818
Jun 200692215
Jul 200661310
Aug 20067119
Sep 2006171313
Oct 2006151718
Nov 2006191210
Dec 2006122318
Jan 2007153025
Feb 200793629
Mar 200752316
Apr 2007162215
May 2007113117
Jun 2007111814
Jul 2007162212
Aug 200761710
Sep 20073129
Oct 2007171824
Nov 20074229
Dec 200729144
Jan 200861811
Feb 2008112310
Mar 2008122319
Apr 2008161510
May 2008211821
Jun 2008233417
Jul 2008222314
Aug 2008132012
Sep 2008322518
Oct 2008442718
Nov 2008342513
Dec 20089109
Jan 200972114
Feb 200982015
Mar 2009272122
Apr 20098179
May 200991614
Jun 20094105
Jul 2009132318
Aug 200941512
Sep 200912155
Oct 2009141811
Nov 200917128
Dec 20092487
Jan 201023129
Feb 20102396
Mar 20105109
Apr 2010201314
May 2010251110
Jun 2010142215
Jul 2010151411
Aug 2010221512
Sep 20109118
Oct 201091410
Nov 201061114
Dec 2010111615
Jan 201151112
Feb 201151012
Mar 2011111716
Apr 2011111216
May 2011141116
Jun 201151718
Jul 20111279
Aug 201191015
Sep 2011101314
Oct 201120158
Nov 201182111
Dec 201191416
Jan 2012101712
Feb 201217912
Mar 2012271017
Apr 2012161612
May 201281015
Jun 201261612
Jul 2012161915
Aug 2012111318
Sep 20127811
Oct 2012101118
Nov 2012211116
Dec 2012869
Jan 20131465
Feb 201312516
Mar 2013171311
Apr 2013748
May 2013122713
Jun 2013485
Jul 20137127
Aug 2013442
Sep 2013997
Oct 201311147
Nov 20138289
Dec 20139176
Jan 201421188
Feb 2014830
Mar 20144106
Apr 201410123
May 2014595
Jun 20146205
Jul 201414104
Aug 2014622
Sep 2014784
Oct 2014556
Nov 20148117
Dec 2014975
Jan 20151775
Feb 2015523
Mar 201519207
Apr 201510156
May 201515115
Jun 2015662
Jul 20154259
Aug 2015464
Sep 201516125
Oct 2015673
Nov 2015642
Dec 20151581
Jan 201620129
Feb 2016264
Mar 201612711
Apr 2016243
May 2016575
Jun 2016898
Jul 2016877
Aug 2016899
Sep 20161385
Oct 201651214
Nov 20169104
Dec 2016075
Jan 20175227
Feb 20170126
Mar 20171152
Apr 20171204
May 20171120
Jun 20171152
Jul 201711710
Aug 20170124
Sep 20170165
Oct 20171104
Nov 20171186
Dec 20170167
Jan 20180147
Feb 201832310
Mar 201824310
Apr 20180256
May 20181228
Jun 20180286
Jul 20180255
Aug 20181227
Sep 20180228
Oct 20184308
Nov 20182151
Dec 20182341
Jan 20192625
Feb 20191700
Mar 20192021
Apr 20191701
May 20192424
Jun 201913110
Jul 2019923
Aug 20192836
Sep 20191755
Oct 20191431
Nov 20192034
Dec 20191231
Jan 20201312
Feb 2020910
Mar 2020712
Apr 20201100
May 2020633
Jun 20202143
Jul 20201400
Aug 2020321
Sep 20201304
Oct 20202632
Nov 20201211
Dec 20202001
Jan 20211231
Feb 20211824
Mar 20212122
Apr 20212120
May 20211873
Jun 20211410
Jul 20211756
Aug 20211432
Sep 20211141
Oct 20213131
Nov 20211810
Dec 20212534
Jan 20222045
Feb 20221823
Mar 20221343
Apr 20222116
May 20222851
Jun 20222121
Jul 20222610
Aug 20222622
Sep 20222773
Oct 20221870
Nov 20223730
Dec 20221931
Jan 20232142
Feb 20231020
Mar 20233433
Apr 20232532
May 20232116

Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 385 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 385, Issue 3
1 Jun 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Orexin 1 Receptor Activation Attenuates Neurogenic Dural Vasodilation in an Animal Model of Trigeminovascular Nociception
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

Orexin 1 Receptor Activation Attenuates Neurogenic Dural Vasodilation in an Animal Model of Trigeminovascular Nociception

P. R. Holland, S. Akerman and P. J. Goadsby
Journal of Pharmacology and Experimental Therapeutics December 1, 2005, 315 (3) 1380-1385; DOI: https://doi.org/10.1124/jpet.105.090951

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNEUROPHARMACOLOGY

Orexin 1 Receptor Activation Attenuates Neurogenic Dural Vasodilation in an Animal Model of Trigeminovascular Nociception

P. R. Holland, S. Akerman and P. J. Goadsby
Journal of Pharmacology and Experimental Therapeutics December 1, 2005, 315 (3) 1380-1385; DOI: https://doi.org/10.1124/jpet.105.090951
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • VTA Muscarinic M5 Receptors and Effort-Choice Behavior
  • Substituted Tryptamine Activity at 5-HT Receptors and SERT
  • KRM-II-81 Analogs
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics